Finanz Nachrichten und Wirtschaft Nachrichten

Kostenlose Pressemitteilungen zu Wirtschaft und Finanzen

Sep
16

Global OEM strategy with a wealth of expertise and experience

Global OEM strategy with a wealth of expertise and experience

Multi-cavity injection mould

Frickenhausen, 15 September 2014 – Greiner Bio-One GmbH, a technology partner for the diagnostic and pharmaceutical industries and the medical sector, is strengthening its position as an OEM developer and producer. In recognition of the company’s growing importance as an original equipment manufacturer, a dedicated global sales organisation for OEM development and production is now being added to its BioScience, Preanalytics and Diagnostics divisions. Appropriately enough, an independent study recently confirmed Greiner Bio-One’s exceptional level of competence in OEM projects.

Greiner Bio-One GmbH develops, produces and distributes plastic laboratory products. It is also a technology partner for hospitals, laboratories, universities, and the diagnostic, pharmaceutical and biotechnology industries. In addition to this core business, Greiner Bio-One is an OEM supplier of customised products for well-known life science and medical companies. To further extend its OEM activities, it is setting up a dedicated global sales organisation.

„We have outstanding expertise in the surface modification of plastics as we have played an active role in plastics processing in the life science and medical sectors for the past 50 years,“ explains Greiner Bio-One’s German Managing Director Heinz Schmid. „This has given us a wealth of experience in development, project planning, production and quality control,“ he adds. A recent study by Nürtingen-Geislingen University confirmed OEM customers‘ high level of satisfaction. The company obtained particularly good ratings in the „Technical development process“, „Manufacturing“ and „Product quality“ categories.

Greiner Bio-One delivers both small and large projects for customers, including everything from simple branding (private labelling) of existing products to specific, custom made solutions as part of a system partnership (true OEM). The product portfolio ranges from basic consumer items to customer-specific medical diagnostic kits. The company also manufactures customised plastic microfluidic product solutions for handling samples and develops individual products for taking samples of bodily fluids such as blood, urine and saliva for preanalytical applications.

Schmid is jointly responsible for OEM activities and is one hundred percent convinced by the company’s strategy. „Our experience and know-how in our core business enables us to stand out from the competition and we also know our customers‘ customers. They use our blood collection tubes and Petri dishes on their equipment and because we know and understand their requirements, we can offer complete solutions that extend from the original idea all the way through to the finished product,“ he says.

Greiner Bio-One GmbH, complete with its new OEM division, will be participating in the CPhl Worldwide pharmaceutical trade fair in Paris, France, from 7 to 9 October 2014.

Bildrechte: Greiner Bio-One

Greiner Bio-One International GmbH
Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into four divisions – Preanalytics, BioScience, Diagnostics and OEM. In 2013, Greiner Bio-One International GmbH generated a turnover of 373 million euros and had over 1,700 employees, 23 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner Holding, which is based in Kremsmünster (Austria).

Greiner Bio-One GmbH – BioScience division
With its BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures as well as microplates for high-throughput screening, thereby allowing extremely fast and efficient drug screening in both industry and research applications.

Greiner Bio-One GmbH – Preanalytics division
Greiner Bio-One’s Preanalytics division develops systems for taking samples of blood, urine and saliva based on the requirements of customers and the diagnostics market. These systems simplify day-to-day routine tasks in clinics, laboratories and medical practices and, above all, make them safer.

Greiner Bio-One GmbH – Diagnostics division
This division encompasses four strategic areas in the field of diagnostics – screening procedures for sexually transmitted diseases, hospital pathogens, vaccine safety and customer-specific products. Two fundamentally different detection systems are able to address the requirements of mass analysis (screening), on the one hand, and the needs of individual analyses in acute medicine, on the other.

Firmenkontakt
Greiner Bio-One GmbH
Frau Sylvia Bauer
Maybachstrasse 2
72636 Frickenhausen
0049-7022-948 0
0049-7022-948-514
marketing@de.gbo.com
https://www.gbo.com/en_DE.html

Pressekontakt
Zeeb Kommunikation GmbH
Frau Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
0711-60 70 719
info@zeeb.info
www.zeeb-kommunikation.de

Andere Pressemitteilungen zu: Allgemein

«

»